Review
Cancer pain
Affiliations
- PMID: 8713631
Item in Clipboard
Review
Cancer pain
Middle East J Anaesthesiol.
1996 Feb.
Abstract
An accurate assessment and where possible a precise diagnosis of the underlying mechanism in necessary for the effective management of pain in cancer. The majority of patients respond to oral analgesics, and the range of drugs required is not vast. Adjuvant analgesic drugs will be needed for the treatment of bone pain, visceral pain and neuropathic pain. For the remaining patients who present with difficult and occasionally intractable pain, a multidisciplinary approach using drug and non-drug measures will usually allow significant relief of symptoms.
Similar articles
-
The management of cancer pain.Md Med J. 1997 Mar;46(3):141-6. Md Med J. 1997. PMID: 9062059 Review.
-
[Mechanism-based pharmacotherapy for cancer pain].Nihon Rinsho. 2001 Sep;59(9):1775-80. Nihon Rinsho. 2001. PMID: 11554051 Review. Japanese.
-
[Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].Ai Zheng. 2007 Aug;26(8):866-9. Ai Zheng. 2007. PMID: 17697549 Chinese.
-
[Drug therapy for pain in cancer patients].Med Klin. 1981 Jan 16;76(2):43-7. Med Klin. 1981. PMID: 6111742 Clinical Trial. German.
-
SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain.Br J Anaesth. 2009 Feb;102(2):251-8. doi: 10.1093/bja/aen347. Epub 2008 Nov 26. Br J Anaesth. 2009. PMID: 19038965